Prognosis of adults and children following a first unprovoked seizure

Neligan, Aidan; Adan, Guleed; Nevitt, Sarah J; Pullen, Angie; Sander, Josemir W.; Bonnett, Laura; Marson, Anthony G

doi:10.1002/14651858.cd013847.pub2

Cited by 8 publications

(20 citation statements)

References 148 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The conclusions of this review should be weighed against those of reviews into early and first seizures of mixed aetiology, to fully understand the influence of precipitation on ictogenesis. 57,94…”

Section: Discussionmentioning

confidence: 99%

“…56 Provoked seizures include those deemed situational or due to acute neurological insult/precipitant. 57 Multivariable model - Prediction models developed with at least two demographic, and/or clinical, and/or neuroimaging, and/or electrophysiological factors collected and assessed as part of standard clinical practice at baseline upon a new diagnosis of epilepsy, that are associated with 12 months continuous seizure freedom (remission). Demographic factors are socioeconomic attributes that can be statistically expressed—for example age, sex, and education level.…”

Section: Methodsmentioning

confidence: 99%

“…56 Provoked seizures include those deemed situational or due to acute neurological insult/precipitant. 57…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Clinical Prediction Models for Treatment Outcomes in Newly-diagnosed Epilepsy

Ratcliffe,

Pradeep,

Marson

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Up to 35% of individuals diagnosed with epilepsy proceed to develop pharmacoresistant epilepsy, leading to persistent uncontrolled seizure activity that can directly, or indirectly, significantly degrade an individual's quality of life. The factors underlying pharmacoresistance are unclear, but it has been hypothesised that repeated ictogenic activity is conducive to the development of a more robust epileptogenic network. To ensure that the most effective treatment choices are made and ictogenic activity is minimised, accurate outcome modelling at the point of diagnosis is key. Objectives: This review therefore aims to identify demographic, clinical, physiological (e.g. EEG), and imaging (e.g. MRI) factors that may be predictive of treatment outcomes in patients with newly diagnosed epilepsy (NDE). Data sources, study eligibility criteria, participants, and interventions: MEDLINE and EMBASE were searched for prediction models of treatment outcomes in patients with newly diagnosed epilepsy and any non-surgical treatment plan. Study appraisal and synthesis methods: Study characteristics were extracted and subjected to assessment of risk of bias (and applicability concerns) using the PROBAST tool. Prognostic factors associated with treatment outcomes are reported. Results: After screening, 48 models were identified in 32 studies, which generally scored low for concerns of applicability, but universally high for susceptibility to bias. Outcomes reported were heterogenous, but fit broadly into four categories: pharmacoresistance, short-term treatment response, seizure remission, and mortality. Prognostic factors were also heterogenous, but the predictors that were commonly significantly associated with outcomes were those related to seizure characteristics (semiology), epilepsy history, and age at onset. ASM response was often included as a prognostic factor, potentially obscuring factor relationships at baseline. Conclusions: Currently, outcome prediction models for NDE demonstrate a high risk of bias. Model development could be improved with a stronger adherence to recommended TRIPOD practices, and by avoiding including response to treatment as a prognostic factor. Implications of key findings: This review identified semiology, epilepsy history, and age at onset as factors associated with treatment outcome prognosis, suggesting that future prediction model studies should focus on these factors in their models. Furthermore, we outline actionable changes to common practices that are intended to improve the overall quality of prediction model development in NDE. Keywords: newly diagnosed epilepsy, seizures, prognosis, intractability, outcomes, treatment

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Prediction Models for Treatment Outcomes in Newly-diagnosed Epilepsy

Ratcliffe,

Pradeep,

Marson

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…The authors of a systematic review and meta-analysis aimed to provide an accurate estimate of the risk of having further unprovoked seizures following a single unprovoked seizure 1. The primary outcome was occurrence of a second unprovoked epileptic seizure more than 24 hours after the original seizure, and this was analysed at 6 months, 12 months, 24 months and beyond.…”

Section: Overviewmentioning

confidence: 99%

“…A Cochrane systematic review and meta-analysis found that the chance of a second unprovoked seizure after a first unprovoked first seizure is 43% after 2 years 1…”

mentioning

confidence: 99%

Risk of recurrence after first unprovoked seizure

2024

DTB

View full text Add to dashboard Cite

show abstract